Evogene Ltd (NASDAQ:EVGN)

1.74
Delayed Data
As of May 17
 +0.039 / +2.29%
Today’s Change
1.67
Today|||52-Week Range
3.46
-12.17%
Year-to-Date
No recent news for Evogene Ltd.

Today’s Trading

Previous close1.70
Today’s open1.68
Day’s range1.68 - 1.74
Volume8,627
Average volume (3 months)33,044
Market cap$44.6M
Data as of 3:56pm ET, 05/17/2019

Growth & Valuation

Earnings growth (last year)+0.49%
Earnings growth (this year)+223.46%
Earnings growth (next 5 years)--
Revenue growth (last year)-48.33%
P/E ratioNM
Price/Sales30.69
Price/Book0.89

Competitors

 Today’s
change
Today’s
% change
VBLTVascular Biogenics L...-0.05-3.85%
ICCCImmuCell Corp-0.08-1.27%
BPTHBio Path Holdings In...-1.23-7.34%
AKTXAkari Therapeutics P...-0.18-6.12%
Data as of 3:59pm ET, 05/17/2019

Financials

Next reporting dateMay 28, 2019
EPS forecast (this quarter)$0.30
Annual revenue (last year)$1.7M
Annual profit (last year)-$20.8M
Net profit margin-1,188.21%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ofer Haviv
Chief Financial Officer
Dorit Kreiner
Corporate headquarters
Rehovot, Hamerkaz

Forecasts